Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance

por Kenicer, Juliet, Spears, Melanie, Lyttle, Nicola, Taylor, Karen J, Liao, Linda, Cunningham, Carrie A, Lambros, Maryou, MacKay, Alan, Yao, Cindy, Reis-Filho, Jorge, Bartlett, John MS
Publicado 2014

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer

por Taylor, Karen J, Sims, Andrew H, Liang, Liang, Faratian, Dana, Muir, Morwenna, Walker, Graeme, Kuske, Barbara, Dixon, J Michael, Cameron, David A, Harrison, David J, Langdon, Simon P
Publicado 2010

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study

por Sgroi, Dennis C., Treuner, Kai, Zhang, Yi, Piper, Tammy, Salunga, Ranelle, Ahmed, Ikhlaaq, Doos, Lucy, Thornber, Sarah, Taylor, Karen J., Brachtel, Elena, Pirrie, Sarah, Schnabel, Catherine A., Rea, Daniel, Bartlett, John M. S.
Publicado 2022

Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer

por Braunstein, Marsela, Liao, Linda, Lyttle, Nicola, Lobo, Nazleen, Taylor, Karen J., Krzyzanowski, Paul M., Kalatskaya, Irina, Yao, Cindy Q., Stein, Lincoln D., Boutros, Paul C., Twelves, Christopher J., Marcellus, Richard, Bartlett, John M. S., Spears, Melanie
Publicado 2016

Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study

por Bartlett, John M.S., Sgroi, Dennis C., Treuner, Kai, Zhang, Yi, Piper, Tammy, Salunga, Ranelle C., Ahmed, Ikhlaaq, Doos, Lucy, Thornber, Sarah, Taylor, Karen J., Brachtel, Elena F., Pirrie, Sarah J., Schnabel, Catherine A., Rea, Daniel W.
Publicado 2022